Receptor tyrosine kinases in the nucleus

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 10, 2013, Pages

  Carpenter, Graham ^a   Liao, Hong Jun ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE FRAGMENT; PROTEIN TYROSINE KINASE; SECRETASE;

ACTIVE TRANSPORT; BIOLOGICAL MODEL; CELL NUCLEUS; METABOLISM; NUCLEAR LOCALIZATION SIGNAL; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW;

ACTIVE TRANSPORT, CELL NUCLEUS; AMYLOID PRECURSOR PROTEIN SECRETASES; CELL NUCLEUS; MODELS, BIOLOGICAL; NUCLEAR LOCALIZATION SIGNALS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84885073436     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a008979     Document Type: Review

References (172)

1. Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson C, Sam-bamurti K. 2009. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through γ-secretase. J Biol Chem 284: 30177-30286.
2. Adilakshmi T, Ness-Myers J, Madrid-Aliste C, Fiser A, Tapi-nos N. 2011. A nuclear variant of ErbB3 receptor tyrosine kinase regulates ezrin distribution and Schwann cell mye-lination. J Neurosci 31: 5106-5119.
3. Aleksic T, Chitnis MM, Perestenko OV, Gao S, Thomas PH, Turner GD, Protheroe AS, Howarth M, Macaulay VM. 2010. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res 70: 6412-6419.
4. Allison JG, Das PM, Ma J, Inglis FM, Jones FE. 2011. The ERBB4 intracellular domain (4ICD) regulates NRG1-in-duced gene expression in hippocampal neurons. Neurosci Res 70: 155-163.
5. Ancot F, Foveau B, Lefebvre J, Leroy C, Tulasne D. 2009. Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity. Oncogene 28: 2185-2195.
6. Andrique L, Fauvin D, El Maassarani M, Colasson H, Van-nier B, Séité P. 2012. ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1promoter to activate cell proliferation but is negatively controlled by p14ARF. Cell Signal 24: 1074-1085.
7. Anido J, Scaltriti M, Bech Serra JJ, Santiago Josefat B, Todo FR, Baselga J, Arribas J. 2006. Biosynthesis of tumorigen-ic HER2 C-terminal fragments byalternative initiation of translation. EMBO J 25: 3234-3244.
8. Arribas J, Baselga J, Pedersen K, Parra-Palau JL. 2011. P95her2 and breast cancer. Cancer Res 71: 1515-1519.
9. Bai G, Chivatakarn O, Bonanomi D, Lettieri K, Franco L, Xia C, Stein E, Ma L, Lewcock JW, Pfaff SL. 2011. Presenilin-dependent receptor processing is required for axon guidance. Cell 144: 106-118.
10. Baron O, Förthmann B, Lee YW, Terranova C, Ratzka A, Stachowiak EK, Grothe C, Claus P, Stachowiak MK. 2012. Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopami-nergic neurons. J Biol Chem 287: 19827-19840.
11. Béguelin W, Díaz FlaquéMC, Proietti CJ, Cayrol F, Rivas MA, Tkach M, Rosemblit C, Tocci JM, Charreau EH, et al. 2010. Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3. Mol Cell Biol 30: 5456-5472.
12. Benoit V, Chariot A, Delacroix L, Deregowski V, Jacobs N, Merville MP, Bours V. 2004. Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor a stimulation is counteracted by nuclear factor kB through c-FLIP-L expression. Cancer Res 64: 2684-2691.
13. Bitler BG, Goverdhan A, Schroeder JA. 2010. MUC1 regulates nuclear localization and function of the epidermal growth factor receptor. J Cell Sci 123: 1716-1723.
14. Bloch L, Sineshchekova O, Reichenbach D, Reiss K, Saftig P, Kuro-o M, Kaether C. 2009. Klotho is a substrate for α-, β- and γ-secretase. FEBS Lett 583: 3221-3224.
15. Bonifacino JS, Rojas R. 2006. Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Cell Mol Biol 7: 563-579.
16. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, Bredesen DE, Edery P, Mehlen P. 2000. The RET proto-oncogene induces apoptosis: A novel mechanism for Hirschsprung disease. EMBOJ 19: 4056-4063.
17. Borlido J, Zecchini V, Mills IG. 2009. Nuclear trafficking and functions of endocytic proteins implicated in oncogene-sis. Traffic 10: 1209-1220.
18. Bray SJ. 2006. Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 7: 678-689.
19. Buchanan SM, Schalm SS, Maniatis T. 2010. Proteolytic processing of protocadherin proteins requires endocyto-sis. Proc Natl Acad Sci 107: 17774-17779.
20. Burgoyne AM, Phillips-Mason PJ, Burden-Gulley SM, Robinson S, Sloan AE, Miller RH, Brady-Kalnay SM. 2009. Proteolytic cleavage of protein tyrosine phospha-tase m regulates glioblastoma cell migration. Cancer Res 69: 6960-6968.
21. Cabrera JR, Bouzas-Rodriguez J, Tauszig-Delamasure S, Mehlen P.2011. RETmodulates cell adhesionvia its cleavage by caspase in sympathetic neurons. J Biol Chem 286: 14628-14638.
22. Cai J, Jiang WG, Grant MB, Boulton M. 2006. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281: 3604-3613.
23. Cai J, Chen Z, Ruan Q, Han S, Liu L, Qi X, Boye SL, Haus-wirth WW, Grant MB, Boulton ME. 2011a. G-Secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1. J Biol Chem 286: 42514-42523.
24. Cai J, Wu L, Qi X, Li Calzi S, Caballero S, Shaw L, Ruan Q, Grant MB, Boulton ME. 2011b. PEDF regulates vascular permeability by a γ-secretase-mediated pathway. PLoS ONE 6: e21164.
25. Carpenter G. 2003. Nuclear localization and possible functions of receptor tyrosine kinases. Curr Opin Cell Biol 15: 143-148.
26. Carpenter G, Liao HJ. 2009. Trafficking of receptor tyrosine kinases to the nucleus. Exp Cell Res 315: 1556-1566.
27. Carson DD. 2008. The cytoplasmic tail of MUC1: A very busy place. Sci Signal 1: e35.
28. Chandra M, Zang S, Li H, Zimmerman LJ, Champer J, Tsuyada A, Chow A, Zhou W, Yu Y, Gao H, et al. 2012. Nuclear translocation of type I transforming growth factor b receptor confers a novel function in RNA processing. Mol Cell Biol 32: 2183-2195.
29. Chaves-Pérez A, Mack B, Maetzel D, Kremling H, Eggert C, Harréus U, Gires O. 2013. EpCAM regulates cell cycle progressionvia control of cyclin D1 expression. Oncogene 32: 641-650.
30. Ceni C, Kommaddi RP, Thomas R, Vereker E, Liu X, McPherson PS, Ritter B, Barker PA. 2010. The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J Cell Sci 123: 2299-22307.
31. Chen CW, Roy D. 1996. Up-regulation of nuclear IGF-I receptor by short term exposure of stilbene estrogen, di-ethylstilbestrol. Mol Cell Endocrinol 118: 1-8.
32. Cheng QC, Tikhomirov O, Zhou W, Carpenter G. 2003. Ectodomain cleavage of ErbB-4: Characterization of the cleavage site and m80 fragment. J Biol Chem 278: 38421- 38427.
33. Chioni AM, Grose R. 2012. FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior. J Cell Biol 197: 801-817.
34. Codony-Servat J, Albanell J, Lopez-Talavera JC, Arribas J, Baselga J. 1999. Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells. Cancer Res 59: 1196-11201.
35. Cousin H, Abbruzzese G, Kerdavid E, Gaultier A, Alfandari D. 2011. Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration. Dev Cell 20: 256-263.
36. De Angelis Campos AC, Rodrigues MA, de Andrade C, de Goes AM, Nathanson MH, Gomes DA. 2011. Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway. Biochem Biophys Res Commun 412: 341-346.
37. Degnin CR, Laederich MB, Horton WA. 2011. Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3. Mol Biol Cell 22: 3861-3873.
38. Deheuninck J, Goormachtigh G, Foveau B, Ji Z, Leroy C, Ancot F, Villeret V, Tulasne D, Fafeur V. 2009. Phosphor-ylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage. Cell Signal 21: 1455-1463.
39. Deng H, Lin Y, Badin M, Vasilcanu D, Strömberg T, Jern-berg-Wiklund H, Sehat B, Larsson O. 2010. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. Biochem Biophys Res Commun 404: 667-671.
40. Denzel S, Maetzel D, Mack B, Eggert C, Bärr G, Gires O. 2009. Initial activation ofEpCAM cleavage via cell-to-cell contact. BMC Cancer 9: 402.
41. De Strooper B, Annaert W. 2010. Novel research horizons for presenilins and γ-secretases in cell biology and disease. Annu Rev Cell Dev Biol 26: 235-260.
42. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R, Rodemann HP. 2005. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 280: 31182-31189.
43. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Kehl-bach R, Rodemann HP. 2010. Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphor-ylation at residue Thr654. FEBS Lett 584: 3878-3884.
44. Domingues I, Rino J, Demmers JA, de Lanerolle P, Santos SC. 2001. VEGFR2 translocates to the nucleus to regulate its own transcription. PLoS ONE 6: e25668.
45. Dunham-Ems SM, Lee YW, Stachowiak EK, Pudavar H, Claus P, Prasad PN. 2009. Stachowiak MK. Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control. Mol Biol Cell 20: 2401-2412.
46. Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD, Klagsbrun M. 1997. A novel juxtamembrane domain iso-form of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem 272: 26761-26768.
47. Feng SM, Muraoka-Cook RS, Hunter D, Sandahl MA, Cas-key LS, Miyazawa K, Atfi A, Earp HS III. 2009. The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation. Mol Cell Biol 29: 892-906.
48. Fortini ME. 2009. Notch signaling: The core pathway and its posttranslational regulation. Dev Cell 16: 633-647.
49. Foveau B, Leroy C, Ancot F, Deheuninck J, Ji Z, Fafeur V, Tulasne D. 2007. Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor. Cell Death Differ 14: 752-764.
50. Foveau B, Ancot F, Leroy C, Petrelli A, Reiss K, Vingtdeux V, Giordano S, Fafeur V, Tulasne D. 2009. Down-regulation of the met receptor tyrosine kinase by presenilin-depen-dent regulated intramembrane proteolysis. Mol Biol Cell 20: 2495-2507.
51. Fox SB, Turley H, Cheale M, Blázquez C, Roberts H, James N, Cook N, Harris A, Gatter K. 2004. Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus. J Pathol 202: 313-320.
52. García-Castillo J, Pedersen K, Angelini PD, Bech-Serra JJ, Colomé N, Cunningham MP, Parra-Palau JL, Canals F, Baselga J, Arribas J. 2009. HER2 carboxyl-terminal fragments regulate cell migration and cortactin phosphory-lation. J Biol Chem 284: 25302-25313.
53. Georgakopoulos A, Xu J, Xu C, Mauger G, Barthet G, Ro-bakis NK. 2011. Presenilin1/γ-secretase promotes the EphB2-induced phosphorylation of ephrinB2 by regulating phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk binding protein. FASEB J 25: 3594-3604.
54. Giri DK, Ali-Seyed M, Li LY, Lee DF, Ling P, Bartholomeusz G, Wang SC, Hung MC. 2005. Endosomal transport of ErbB-2: Mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 25: 11005-11018.
55. Giulianelli S, Cerliani JP, Lamb CA, Fabris VT, Bottino MC, Gorostiaga MA, Novaro V, Góngora A, Baldi A, Molinolo A, et al. 2008. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/ FGFR-2 axis. Int J Cancer 123: 2518-2531.
56. Glenn G, van der Geer P. 2007. CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor. FEBS Lett 581: 5377-5381.
57. Glenn G, van der Geer P. 2008. Toll-like receptors stimulate regulated intramembrane proteolysis of the CSF-1 receptor through Erk activation. FEBS Lett 582: 911-915.
58. Goldschneider D, Rama N, Guix C, Mehlen P. 2008. The neogenin intracellular domain regulates gene transcription via nuclear translocation. Mol Cell Biol 28: 4068-4079.
59. Golubkov VS, Strongin AY. 2012. Insights into ectodomain shedding and processing of protein-tyrosine pseudoki-nase 7 (PTK7). J Biol Chem 287: 42009-42018.
60. Gomes DA, Rodrigues MA, Leite MF, Gomez MV, Varnai P, Balla T, Bennett AM, Nathanson MH. 2008. c-Met must translocate to the nucleus to initiate calcium signals. J Biol Chem 283: 4344-4351.
61. Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Ar-royave R, Vijayakumar S, Economides AN, Aaronson SA. 2010. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24: 2517-2530.
62. Han J, Allalunis-Turner J, Hendzel MJ. 2011. Characterization and comparison of protein complexes initiated by the intracellular domain of individual Notch paralogs. Biochem Biophys Res Commun 407: 479-485.
63. Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y, Hung MC. 2006. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol Carcinog 45: 10-17.
64. He G, Luo W, Li P, Remmers C, Netzer WJ, Hendrick J, Bettayeb K, Flajolet M, Gorelick F, Wennogle LP, et al. 2010. γ-Secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 467: 95-98.
65. Hoeing K, Zscheppang K, Mujahid S, Murray S, Volpe MV, Dammann CE, Nielsen HC. 2011. Presenilin-1 processing of ErbB4 in fetal type II cells is necessary for control of fetal lung maturation. Biochim Biophys Acta 1813: 480-491.
66. Hsu SC, Hung MC. 2007. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J Biol Chem 282: 10432-10440.
67. Huang WC, Chen YJ, Li LY, Wei YL, Hsu SC, Tsai SL, Chiu PC, Huang WP, Wang YN, Chen CH, etal. 2011a. Nuclear translocationof epidermal growth factor receptorbyAkt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells. J Biol Chem 286: 20558-20568.
68. Huang HP, Chen PH, Yu CY, Chuang CY, Stone L, Hsiao WC, Li CL, Tsai SC, Chen KY, Chen HF, et al. 2011b. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripo-tency reprogramming. J Biol Chem 286: 33520-33532.
69. Janiszewska M, De Vito C, Le Bitoux MA, Fusco C, Stamen-kovic I. 2010. Transportin regulates nuclear import of CD44. J Biol Chem 285: 30548-30557.
70. Jones FE. 2008. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer. J Mammary Gland Biol Neoplasia 13: 247-258.
71. Kagawa H, Shino Y, Kobayashi D, Demizu S, Shimada M, Ariga H, Kawahara H. 2011. A novel signaling pathway mediated by the nuclear targeting of C-terminal fragments of mammalian Patched 1. PLoS ONE 6: e18638.
72. Kasuga K, Kaneko H, Nishizawa M, Onodera O, Ikeuchi T. 2007. Generation of intracellular domain of insulin re ceptor tyrosine kinase by γ-secretase. Biochem Biophys Res Commun 360: 90-96.
73. Kim J, Jahng WJ, Di Vizio D, Lee JS, Jhaveri R, Rubin MA, Shisheva A, Freeman MR. 2007. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res 67: 9229-9237.
74. Kopan R, Ilagan MX. 2004. G-Secretase: Proteasome of the membrane? Nat Rev Mol Cell Biol 5: 499-504.
75. Lai C, Feng L. 2004. Implication of γ-secretase in neuregu-lin-induced maturation of ligodendrocytes. Biochem Bio-phys Res Commun 314: 535-542.
76. Lal M, Caplan M. 2011. Regulated intramembrane proteolysis: Signaling pathways and biological functions. Physiology (Bethesda) 26: 34-44.
77. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, Avraham S. 2007. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med 4: e186.
78. Lemberg MK. 2011. Intramembrane proteolysis in regulated protein trafficking. Traffic 12: 1109-1118.
79. Le Moan N, Houslay DM, Christian F, Houslay MD, Akas-soglou K. 2011. Oxygen-dependent cleavage of the p75 neurotrophin receptor triggers stabilization of HIF-1a. Mol Cell 44: 476-490.
80. Li LY, Chen H, Hsieh YH, Wang YN, Chu HJ, Chen YH, Chen HY, Chien PJ, Ma HT, Tsai HC, et al. 2011. Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes. Cancer Res 71: 4269-4279.
81. Liao HJ, Carpenter G. 2007. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol Biol Cell 18: 1064-1072.
82. Liao HJ, Carpenter G. 2009. Cetuximab/C225-induced in-tracellular trafficking of epidermal growth factor receptor. Cancer Res 69: 6179-6183.
83. Liao HJ, Carpenter G. 2012. Regulated intramembrane cleavage of the EGF receptor. Traffic 13: 1106-1112.
84. Liccardi G, Hartley JA, Hochhauser D. 2011. EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res 71: 1103- 1114.
85. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808.
86. Lin KT, Sloniowski S, Ethell DW, Ethell IM. 2008. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J Biol Chem 283: 28969-28979.
87. Litterst C, Georgakopoulos A, Shioi J, Ghersi E, Wisniewski T, Wang R, Ludwig A, Robakis NK. 2007. Ligand binding and calcium influx induce distinct ectodomain/γ-secre-tase-processing pathways of EphB2 receptor. J Biol Chem 282: 16155-16163.
88. Liu HS, Hsu PY, Lai MD, Chang HY, Ho CL, Cheng HL, Chen HT, Lin YJ, Wu TJ, Tzai TS, et al. 2010. An unusual function of RON receptor tyrosine kinase as a transcrip-tional regulator in cooperation with EGFR in human cancer cells. Carcinogenesis 31: 1456-1464.
89. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia X, Wei Y, Bartholomeusz G, Shih JY, Hung MC. 2005. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7: 575-589.
90. Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, Hung MC. 2006. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin b1 and CRM1. J Cell Biochem 98: 1570-1583.
91. Lo HW, Cao X, Zhu H, Ali-Osman F. 2010. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STA3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res 8: 232-245.
92. López-Otín C, Hunter T. 2010. The regulatory crosstalk between kinases and proteases in cancer. Nat RevCancer 10: 278-292.
93. Lu P, Ewald AJ, Martin GR, Werb Z. 2004. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 321: 77-87.
94. Lyu J, Yamamoto V, Lu W. 2008. Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell 15: 773-780.
95. Lyu J, Wesselschmidt RL, Lu W. 2009. Cdc37 regulates Ryk signaling by stabilizing the cleaved Ryk intracellular domain. J Biol Chem 284: 12940-12948.
96. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, et al. 2009. Nuclear signalling by tumour-associated antigen Ep-CAM. Nat Cell Biol 11: 162-171.
97. Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, Koh GY, Brindle NP. 2007. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-ty-rosine kinase Tie2. J Biol Chem 282: 30509-30517.
98. Martin AJ, Grant A, Ashfield AM, Palmer CN, Baker L, Quinlan PR, Purdie CA, Thompson AM, Jordan LB, Berg JN. 2011. FGFR2 protein expression in breast cancer: Nuclear localization and correlation with patient genotype. BMC Res Notes 4: 72.
99. Mathew D, Ataman B, Chen J, Zhang Y, Cumberledge S, Budnik V. 2005. Wingless signaling at synapses isthrough cleavage and nuclear import of receptor DFrizzled2. Science 310: 1344-1347.
100. Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL, Pandya D, Lu Y, Mills GB, Aster JC, et al. 2010. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci 107: 5012-5017.
101. McCarthy JV, Twomey C, Wujek P. 2009. Presenilin-depen-dent regulated intramembrane proteolysis and γ-secre-tase activity. Cell Mol Life Sci 66: 1534-1555.
102. McElroy B, Powell JC, McCarthy JV. 2007. The insulin-like growth factor 1 (IGF-1) receptor is a substrate for γ-sec-retase-mediated intramembrane proteolysis. Biochem Bi-ophys Res Commun 358: 1136-1141.
103. Merlin J, Stechly L, de BeaucéS, Monté D, Leteurtre E, van Seuningen I, Huet G, Pigny P. 2011. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Oncogene 30: 2514-2525.
104. Migaki GI, Kahn J, Kishimoto TK. 1995. Mutational analysis of the membrane-proximal cleavage site of l-selectin: Relaxed sequence specificity surrounding the cleavage site. J Exp Med 182: 549-557.
105. Miletti-González KE, Murphy K, Kumaran MN, Ravindra-nath AK, Wernyj RP, Kaur S, Miles GD, Lim E, Chan R, Chekmareva M, et al. 2012. Identification of function for CD44 intracytoplasmic domain (CD44-ICD): Modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element. J Biol Chem 287: 18995-19007.
106. Montes de Oca P, Malardé V, Proust R, Dautry-Varsat A, Gesbert F. 2010. Ectodomain shedding of interleukin-2 receptor b and generation of an intracellular functional fragment. J Biol Chem 285: 22050-22058.
107. Mourali J, Bénard A, Lourenço FC, Monnet C, Greenland C, Moog-Lutz C, Racaud-Sultan C, Gonzalez-Dunia D, Vigny M, Mehlen P, et al. 2006. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol 26: 6209-6222.
108. Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, Yakymo-vych M, Hermansson A, Dimitriou H, Bengoechea-Alonso MT, Ericsson J, et al. 2011. TRAF6 ubiquitinates TGF-β type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2: 330.
109. Muraoka-Cook RS, Sandahl M, Husted C, Hunter D, Mir-aglia L, Feng SM, Elenius K, Earp HS. 2006. The intra-cellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol Biol Cell 17: 4118-4129.
110. Na HW, Shin WS, Ludwig A, Lee ST. 2012. The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavagebya disintegrin and metallopro-tease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells. J Biol Chem 287: 25001-25009.
111. Naresh A, Long W, Vidal GA, Wimley WC, Marrero L, Sartor CI, Tovey S, Cooke TG, Bartlett JM, Jones FE. 2006. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res 66: 6412-6420.
112. Ni CY, Murphy MP, Golde TE, Carpenter G. 2001. G-Secre-tase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294: 2179-2181.
113. Ni CY, Yuan H, Carpenter G. 2003. Role of the ErbB-4 carboxyl terminus in γ-secretase cleavage. J Biol Chem 278: 4561-4565.
114. Offterdinger M, Schofer C, Weipoltshammer K, Grunt TW. 2002. C-erbB-3: A nuclear protein in mammaryepithelial cells. J Cell Biol 157: 929-939.
115. Omerovic J, Santangelo L, Puggioni EM, Marrocco J, Dall'-Armi C, Palumbo C, Belleudi F, Di Marcotullio L, Frati L, Torrisi MR, et al. 2007. The E3 ligase Aip4/Itch ubiqui-tinates and targets ErbB-4 for degradation. FASEB J 21: 2849-2862.
116. Paatero I, Jokilammi A, Heikkinen PT, Iljin K, Kallioniemi OP, Jones FE, Jaakkola PM, Elenius K. 2012. Interaction with ErbB4 promotes hypoxia-inducible factor-1a signaling. J Biol Chem 287: 9659-9671.
117. Pan B, Huang XF, Deng C. 2011. Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35: 924-930.
118. Parkhurst CN, Zampieri N, Chao MV. 2010. Nuclear localization of the p75 neurotrophin receptor intracellular domain. J Biol Chem 285: 5361-5368.
119. Pedersen K, Angelini PD, Laos S, Bach-Faig A, Cunningham MP, Ferrer-Ramón C, Luque-García A, García-Castillo J, Parra-Palau JL, Scaltriti M, et al. 2009. A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis. Mol Cell Biol 29: 3319-3331.
120. Piccione EC, Lieu TJ, Gentile CF, Williams TR, Connolly AJ, Godwin AK, Koong AC, Wong AJ. 2012. A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overex-pressed in tumors. Oncogene 31: 2953-2967.
121. Pozner-Moulis S, Pappas DJ, Rimm DL. 2006. Met, the he-patocyte growth factor receptor, localizes to the nucleus in cells at low density. Cancer Res 66: 7976-7982.
122. Racaud-Sultan C, Gonzalez-Dunia D, Vigny M, Mehlen P, Delsol G, Allouche M. 2006. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are ctivated by caspase cleavage. Mol Cell Biol 26: 6209-6222.
123. Rahimi N, Golde TE, Meyer RD. 2009. Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells. Cancer Res 69: 2607-2614.
124. Ralhan R, He HC, So AK, Tripathi SC, Kumar M, Hasan MR, Kaur J, Kashat L, MacMillan C, Chauhan SS, et al. 2010. Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers. PLoS ONE 5: e14130.
125. Rebeck GW. 2009. Nontraditional signaling mechanisms of lipoprotein receptors. Sci Signal 2: e28.
126. Rio C, Buxbaum JD, Peschon JJ, Corfas G. 2000. Tumor necrosis factor-a-converting enzyme is required for cleavage oferbB4/HER4.J Biol Chem 275: 10379-10387.
127. Rokicki J, Das PM, Giltnane JM, Wansbury O, Rimm DL, Howard BA, Jones FE. 2010. The ERa coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Mol Cancer 9: 150.
128. Sandvig K, van Deurs B. 2002. Transport of protein toxins into cells: Pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett 529: 49-53.
129. Santos SC, Dias S. 2004. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 103: 3883-3889.
130. Santos SC, Miguel C, Domingues I, Calado A, Zhu Z, Wu Y, Dias S. 2007. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res 313: 1561-1574.
131. Sardi SP, Murtie J, Koirala S, Patten BA, Corfas G. 2006. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127: 185-197.
132. Schmahl J, Kim Y, Colvin JS, Ornitz DM, Capel B.2004. Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development 131: 3627-3636.
133. Sehat B, Tofigh A, Lin Y, Trocmé E, Liljedahl U, Lagergren J, Larsson O. 2010. SUM Oylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 3: ra10.
134. Selkoe DJ, Wolfe MS. 2007. Presenilin: Running with scissors in the membrane. Cell 131: 215-221.
135. Shah S, Lee SF, Tabuchi K, Hao HY, Yu C, LaPlant Q, Ball H, Dann CE, Sudhof T, Yu G. 2005. Nicastrin functions as a γ-secretase-substrate receptor. Cell 122: 435-447.
136. Small DH. 2002. Is γ-secretase a multienzyme complex for membrane protein degradation? Models and speculations. Peptides 23: 1317-1321.
137. Stachowiak MK, Maher PA, Stachowiak EK. 2007. Integra-tive nuclear signaling in cell development-A role for FGF receptor-1. DNA Cell Biol 26: 811-826.
138. Stewart M, Turley H, Cook N, Pezzella F, Pillai G, Ogilvie D, Cartlidge S, Paterson D, Copley C, Kendrew J, et al. 2003. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology 43: 33-39.
139. Stoeck A, Shang L, Dempsey PJ. 2010. Sequential and γ-secretase-dependent processing of the β-cellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth. J Cell Sci 123: 2319-2331.
140. Strohecker AM, Yehiely F, Chen F, Cryns VL. 2008. Caspase cleavage of HER-2 releases a bad-like cell death effector. J Biol Chem 283: 18269-18282.
141. Struhl G, Adachi A. 2000. Requirements for presenilin-de-pendent cleavage of notch and other transmembrane proteins. Mol Cell 6: 625-636.
142. Tagami S, Okochi M, Yanagida K, Ikuta A, Fukumori A, Matsumoto N, Ishizuka-Katsura Y, Nakayama T, Itoh N, Jiang J, et al. 2008. Regulation of Notch signaling by dynamic changes in the precision of S3 cleavage of Notch-1. Mol Cell Biol 28: 165-176.
143. Tao Y, Song X, Deng X, Xie D, Lee LM, Liu Y, Li W, Li L, Deng L, Wu Q, et al. 2005. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. Exp Cell Res 303: 240-251.
144. Tauszig-Delamasure S, Yu LY, Cabrera JR, Bouzas-Rodriguez J, Mermet-Bouvier C, Guix C, Bordeaux MC, Arumae U, Mehlen P. 2007. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neuro-trophin paradigm. Proc Natl Acad Sci 104: 13361-13366.
145. Thor AD, Edgerton SM, Jones FE. 2009. Subcellular localization of the HER4 ntracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients. Am J Pathol 175: 1802-1809.
146. Tikhomirov O, Carpenter G. 2001. Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin. J Biol Chem 276: 33675-33680.
147. Tomita T, Tanaka S, Morohashi Y, Iwatsubo T. 2006. Prese-nilin-dependent intramembrane cleavage of ephrin-B1. Mol Neurodegener 1: 2.
148. Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Ko-nietzko U, Reiss K, Maes E, Snellinx A, Serneels L, Nyabi O, et al. 2009. ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the γ-secretase. J Biol Chem 284: 11738-11747.
149. Tulasne D, Deheuninck J, Lourenco FC, Lamballe F, Ji Z, Leroy C, Puchois E, Moumen A, Maina F, Mehlen P, et al. 2004. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol Cell Biol 24: 10328-10339.
150. Varshavsky A. 1997. The N-end rule pathway of protein degradation. Genes Cells 2: 13-28.
151. Vecchi M, Baulida J, Carpenter G. 1996. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem 271: 18989-18995.
152. Veikkolainen V, Vaparanta K, Halkilahti K, Iljin K, Sundvall M, Elenius K. 2011. Function of ERBB4 is determined by alternative splicing. Cell Cycle 10: 2647-2657.
153. Vidal GA, Naresh A, Marrero L, Jones FE. 2005. Presenilin-dependent γ-secretase processing regulates multiple ERBB4/HER4 activities. J Biol Chem 280: 19777-19783.
154. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, et al. 2004. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6: 251-261.
155. Wang SC, Nakajima Y, Yu YL, Xia W, Chen CT, Yang CC, McIntush EW, Li LY, Hawke DH, Kobayashi R, et al. 2006. Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 8: 1359-1368.
156. Wang X, Cui M, Wang L, Chen X, Xin P. 2010a. Inhibition of neurotrophin receptor p75 intramembran proteolysis by γ-secretase inhibitor reduces medulloblastoma spinal metastasis. Biochem Biophys Res Commun 403: 264-269.
157. Wang YN, Yamaguchi H, Huo L, Du Y, Lee HJ, Lee HH, Wang H, Hsu JM, Hung MC. 2010b. The translocon Sec61b localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus. J Biol Chem 285: 38720-38729.
158. Wang YN, Yamaguchi H, Hsu JM, Hung MC. 2010c. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 29: 3997-4006.
159. Wang X, Cowan JW, Gerhart M, Zelickson BR, Jiang J, He K, Wolfe MS, Black RA, Frank SJ. 2011a. G-Secretase-medi-ated growth hormone receptor proteolysis: Mapping of the intramembranous cleavage site. Biochem Biophys Res Commun 408: 432-436.
160. Wang YN, Wang H, Yamaguchi H, Lee HJ, Lee HH, Hung MC. 2011b. COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport. Biochem Biophys Res Commun 399: 498-504.
161. Wang YN, Lee HH, Lee HJ, Du Y, Yamaguchi H, Hung MC. 2012. Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. J Biol Chem 287: 16869-16879.
162. Wilhelmsen K, van der Geer P. 2004. Phorbol 12-myristate 13-acetate-induced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage events. Mol Cell Biol 24: 454-464.
163. Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE. 2004. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 167: 469- 478.
164. Wong J, Weickert CS. 2009. Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia. J Biol Chem 284: 18824-18832.
165. Xia W, Liu Z, Zong R, Liu L, Zhao S, Bacus SS, Mao Y, He J, Wulfkuhle JD, Petricoin EF III, et al. 2011. Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors. Mol Cancer Ther 10: 1367-1374.
166. Yu YL, Chou RH, Wu CH, Wang YN, Chang WJ, Tseng YJ, Chang WC, Lai CC, Lee HJ, Huo L, et al. 2012. Nuclear EGFR suppresses ribonuclease activity of poly-nucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. J Biol Chem 287: 31015-31026.
167. Zeng F, Zhang MZ, Singh AB, Zent R, Harris RC. 2007. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis. Mol Biol Cell 18: 4446-4456.
168. Zeng F, Xu J, Harris RC. 2009. Nedd4 mediates ErbB4 JM-a/ CYT-1 ICD ubiquitination and degradation in MDCK II cells. FASEB J 23: 1935-1945.
169. Zhang Y, Pillai G, Gatter K, Blázquez C, Turley H, Pezzella F, Watt SM. 2005. Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: An immunohistochem-ical study. Hum Pathol 36: 797-805.
170. Zhou W, Carpenter G. 2000. Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem 275: 34737-34743.
171. Zscheppang K, Dörk T, Schmiedl A, Jones FE, Dammann CE. 2011a. Neuregulin receptor ErbB4 functions as a transcriptional cofactor for the expression of surfactant protein B in the fetal lung. Am J Respir Cell Mol Biol 45: 761-767.
172. Zscheppang K, Konrad M, Zischka M, Huhn V, Dammann CE. 2011b. Estrogen-induced upregulation of Sftpb requires transcriptional control of neuregulin receptor ErbB4 in mouse lung type II epithelial cells. Biochim Biophys Acta 1813: 1717-1727.